City of Hope takes a Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

 

Berlin, Germany and Duarte, USA, June 9, 2021:

ProBioGen AG has announced a commercial product license agreement with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening…

More

Myelo Therapeutics Receives Additional NIAID Funding to Advance Development of Myelo001 for Acute Radiation Syndrome

Myelo Therapeutics GmbH, a clinical-stage pharmaceutical company focused on developing medical countermeasures (MCM) and therapies for cancer supportive care, announced today that the U.S. National Institute of Allergy and Infectious Diseases…

More

Eckert & Ziegler and Telix Pharmaceuticals Enter Co-Promotion Agreement for Prostate Cancer Diagnostic in the United States

Eckert & Ziegler (ISIN DE0005659700, TecDAX) and Telix Pharmaceuticals (Telix) will cooperate closely in the commercialization of GalliaPharm® (68Ge/68Ga Generator) and investigational product Illuccix® (Kit for the preparation of Ga-68 PSMA-11…

More

G4A: Growth Track

 

Deadline: June 20th, 2021

The Growth Track is our offer for early to mid-stage startups. This track is a good fit for Seed and Series A startups with a minimal viable product validated through patents and publications. And of course, a stellar and…

More

Seed round oversubscribed: Bluu Biosciences secures €7 million – Europe's first cell-based fish biotech company takes off

Berlin-based biotech Bluu Biosciences has closed its seed funding round at 7 million euros less than ten months after its foundation. Bluu Biosciences is the first company in Europe to specialize in the development and production of cell-based fish.…

More

ProBioGen and Minapharm incorporate subsidiary

The company will enhance accessibility to medicines for Egypt, the Middle East and Africa while strengthening regional and local manufacturing capacities

More

Learnings from Covid-19 & Partnership Opportunities with Bayer G4A

Fr., 4. Juni · 17:00 MESZ

Details

Join one of our webinars to gain insights about this year’s partnership opportunities for digital health innovators with Bayer G4A!

We will reflect on the implications of the Covid-19 pandemic for digital health…

More

The winner of the 2021 Speed Lecture Award is Bruna Seco from the Max Planck Institute of Colloids and Interfaces

Berlin, May 12, 2021 - Today the 15th Speed Lecture Award took place as part of BIONNALE, again as a live-stream and with over 750 registrations.

More
Show more items